Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Definitive Healthcare (DH) over the last 6 years, with Q3 2025 value amounting to $108.3 million.

  • Definitive Healthcare's Cash & Equivalents fell 2128.64% to $108.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.3 million, marking a year-over-year decrease of 2128.64%. This contributed to the annual value of $105.4 million for FY2024, which is 1954.4% down from last year.
  • Latest data reveals that Definitive Healthcare reported Cash & Equivalents of $108.3 million as of Q3 2025, which was down 2128.64% from $81.0 million recorded in Q2 2025.
  • In the past 5 years, Definitive Healthcare's Cash & Equivalents ranged from a high of $387.5 million in Q4 2021 and a low of $77.5 million during Q3 2023
  • In the last 5 years, Definitive Healthcare's Cash & Equivalents had a median value of $131.0 million in 2023 and averaged $155.4 million.
  • Per our database at Business Quant, Definitive Healthcare's Cash & Equivalents skyrocketed by 146413.18% in 2021 and then crashed by 6614.92% in 2023.
  • Definitive Healthcare's Cash & Equivalents (Quarter) stood at $387.5 million in 2021, then tumbled by 62.08% to $146.9 million in 2022, then decreased by 10.86% to $131.0 million in 2023, then fell by 19.54% to $105.4 million in 2024, then grew by 2.79% to $108.3 million in 2025.
  • Its Cash & Equivalents stands at $108.3 million for Q3 2025, versus $81.0 million for Q2 2025 and $106.1 million for Q1 2025.